Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated With Diabetic Neuropathy.

NCT05301816 is registered in ClinicalTrials.gov with Nevro Corp as lead sponsor.

NCT NCT05301816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05301816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated With Diabetic Neuropathy.
Lead sponsor
Nevro Corp
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 5, 2022
Completion date
October 31, 2028
Enrollment
497 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful